Zilucoplan May Decrease Symptoms of Myasthenia Gravis Zilucoplan May Decrease Symptoms of Myasthenia Gravis

The novel self-administered subcutaneous agent is safe and relatively well tolerated in generalized myasthenia gravis, a new phase 2 trial and extension study report.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news